A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non-muscle-invasive bladder cancer. [electronic resource]
- Urologic oncology 06 2020
- 606-607 p. digital